ArticleJournal for immunotherapy of cancer2025

Dual-faced CXCL5 holds the key to unlocking immunotherapy in obese pancreatic cancer.

Liping Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.